| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |